Aqualung Therapeutics leadership are experienced academic leaders and scientists who have driven NAMPT as a druggable target.
Joe "Skip" G.N. Garcia, MD
Founder and Chief Executive Officer
Currently the University of Arizona endowed Merlin K. DuVal MD Professor of Medicine and an elected member of the Institute of Medicine of the National Academies, Dr. Garcia is a physican-scientist with over 30 yrs of research experience in pulmonary disease.
Mike Jonen, Executive MBA
Chief Finance Officer
Over 20 years of business and high-level academic health sciences administrative experience.
Eddie T. Chiang, MA
Chief Operating Officer
Expertise in vascular biology research and over 15 years in the Garcia research group.
Sara M. Camp, BA
Chief Research Officer
Specializes in the genomic and proteomic studies of lung injury with over 15 years experience with the Garcia research group.